Abiopharma

Intelligent Bio Solutions Inc. - Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission

Gilead - Gilead’s Livdelzi® (Seladelpar) Delivers Statistically Significant Composite ALP Normalization in Phase 3 IDEAL Trial in Primary Biliary Cholangitis (PBC)

IceCure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance

Inventiva annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris

Inventiva Announces Trading Resumption of its Ordinary Shares on Euronext Paris

Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors

Financial Statements Q1 2026 Investor Presentation

Universal Display Corporation Expands China Presence with Grand Opening of Chengdu OLED Technology and Innovation Center

Wiley Acquires Emerald, Expanding Research Scale and Deepening Proprietary Content Across the AI-Driven Knowledge Economy

Quoin Pharmaceuticals Submits IND Application for QRX003 in Peeling Skin Syndrome